
Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
Darmstadt, Germany, and Rehovot, Israel, February 16, 2016 – Merck, a leading science and technology company, announced that the Weizmann Institute conferred the renowned Weizmann Award in the Sciences and Humanities to Karl-Ludwig Kley, CEO and Chairman of the Executive Board and of Merck.
EcoPhage
EcoPhage is focused on discovering and developing environmentally friendly products for disease control in agriculture. The company's technology uses bacteriophages (viruses that attack bacteria) for crop protection.

Metabolic Insights
Metabolic Insights aims to develop novel eco-friendly and sustainable products based on purified molecules from plants.

FortePhest
FortePhest is a biotechnology start-up developing a technology to combat herbicide‐resistant weeds.

Liposphere
Liposphere is a biomedical start-up developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in the human body where ultra-low friction is important.

Cell Source
Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company's patented Veto Cell technology enables safe and selective tuning of immune responses.

Curesponse
Curesponse is a clinical-stage cancer diagnostics company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.

UltraSight (Previously OnSight Medical)
UltraSight, a joint venture of Yeda and NYU, has developed AI-based software that revolutionizes point of care diagnosis using ultrasound imaging, by eliminating the need for an expert.


Pages
